Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to sign and date a consent form agreeing to take part in the study.
- People who are available for the full length of the study and willing to follow all study procedures, including doing twice-daily irrigation (rinsing) of their neobladder or ileal conduit (types of urinary diversion created after bladder removal).
- People who are male or female and aged 18 or older.
- People who have been diagnosed with bladder cancer.
- People whose medical team has determined that removal of the bladder with urinary diversion surgery is the appropriate treatment plan.
- People with a general health and activity level rated at 0, 1, or 2 on a standard medical scale, meaning they are able to carry out at least some daily activities independently (confirm with trial site).
- People whose blood test shows a kidney function measurement (serum creatinine) of 1.5 mg/dL or lower.
Who may not be able to join:
- People who have already had, or are planned to have, a type of urinary diversion other than an ileal conduit or neobladder.
- People who are pregnant or breastfeeding.
- People with a known allergy to chlorhexidine or any other component of the Irrisept irrigating system used in this study.
- People with any serious uncontrolled health condition — such as an active infection, heart failure, unstable chest pain, irregular heartbeat, or a mental health or personal situation — that the study doctor believes would make it difficult to follow the study requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: John P Sfakianos, MD, Associate Professor of Urology
Phone: (212) 241-0751
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants that have negative urine culture; Proportion of participants with incident symptomatic UTI
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.